http://www.********.au/2016/07/20/why-these-4-stocks-are-going-gangbusters-today/
Resapp Health Ltd (ASX: RAP) shares are up 6.3% to 34 cents this morning after it announced a partnership with Massachusetts General Hospital to conduct a clinical study aimed at gathering evidence for a potential submission to the US FDA. ResApp develops smartphone medical applications for the diagnosis and management of respiratory diseases and has an evangelical-like following of retail shareholders hoping the company can deliver on its potential. The market cap is nearly $200 million – large for a company with no revenues and a net operating cash flow loss of $612,000 for the quarter ending 31 March 2016, although it reportedly has some exciting potential.
- Forums
- ASX - By Stock
- RAP
- Motley Fool Likes RAP
Motley Fool Likes RAP
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)